Yi‐Heng Li

1.3k total citations
67 papers, 752 citations indexed

About

Yi‐Heng Li is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yi‐Heng Li has authored 67 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Cardiology and Cardiovascular Medicine, 34 papers in Surgery and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yi‐Heng Li's work include Lipoproteins and Cardiovascular Health (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Yi‐Heng Li is often cited by papers focused on Lipoproteins and Cardiovascular Health (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Yi‐Heng Li collaborates with scholars based in Taiwan, China and United States. Yi‐Heng Li's co-authors include Ting‐Hsing Chao, Liang‐Miin Tsai, Li‐Jen Lin, Ju‐Yi Chen, Hung‐I Yeh, Sheng‐Hsiang Lin, Ping‐Yen Liu, Ching‐Lin Hsieh, Chau‐Chung Wu and Jyh-Hong Chen and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Yi‐Heng Li

58 papers receiving 741 citations

Peers

Yi‐Heng Li
Songbai Deng China
C. Abletshauser Germany
Pyung Chun Oh South Korea
Simon Kouz Canada
Binh An P. Phan United States
Tadeusz Osadnik Poland
Fabio Marsico Italy
Michael J. Blaha United States
Marija Vavlukis North Macedonia
Pierre Sabouret France
Songbai Deng China
Yi‐Heng Li
Citations per year, relative to Yi‐Heng Li Yi‐Heng Li (= 1×) peers Songbai Deng

Countries citing papers authored by Yi‐Heng Li

Since Specialization
Citations

This map shows the geographic impact of Yi‐Heng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Heng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Heng Li more than expected).

Fields of papers citing papers by Yi‐Heng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Heng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Heng Li. The network helps show where Yi‐Heng Li may publish in the future.

Co-authorship network of co-authors of Yi‐Heng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Heng Li. A scholar is included among the top collaborators of Yi‐Heng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Heng Li. Yi‐Heng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yen‐Wen, Tsung‐Hsien Lin, Wayne Huey‐Herng Sheu, et al.. (2024). Recent trends of low-density lipoprotein cholesterol control and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Taiwan: 2015–2020. Journal of the Formosan Medical Association. 124(5). 419–425.
2.
Lin, Hui‐Wen, et al.. (2024). Risk of Hemorrhagic Stroke among Patients Treated with High-Intensity Statins versus Pitavastatin-Ezetimibe: A Population Based Study. The Tohoku Journal of Experimental Medicine. 263(2). 105–113.
3.
4.
Lin, Fang‐Ju, Chin‐Feng Hsuan, Chih‐Fan Yeh, et al.. (2023). A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation study. Biomedical Journal. 47(3). 100653–100653. 1 indexed citations
5.
Sim, David, Weiqin Lin, Andrew Sindone, et al.. (2023). Asian Pacific Society of Cardiology Consensus Statements on the Diagnosis and Management of Chronic Heart Failure. 2. 7 indexed citations
6.
Chang, Wei‐Ting, Hui‐Wen Lin, Sheng‐Hsiang Lin, & Yi‐Heng Li. (2023). Association of Statin Use With Cancer- and Noncancer-Associated Survival Among Patients With Breast Cancer in Asia. JAMA Network Open. 6(4). e239515–e239515. 24 indexed citations
7.
Chang, Wei‐Ting, et al.. (2023). The association between tyrosine kinase inhibitors and fatal arrhythmia in patients with non-small cell lung cancer in Taiwan. Frontiers in Oncology. 13. 1172036–1172036. 4 indexed citations
8.
Wu, Lei, Yan Deng, Guangyao Shi, et al.. (2022). Synthesis and application of visual AIE fluorescent probe for lipid droplets in vivo. Dyes and Pigments. 209. 110946–110946. 2 indexed citations
9.
Huang, Po‐Hsun, Ya‐Wen Lu, Yi‐Lin Tsai, et al.. (2022). 2022 Taiwan lipid guidelines for primary prevention. Journal of the Formosan Medical Association. 121(12). 2393–2407. 17 indexed citations
10.
Qin, Wei, Yi‐Heng Li, Jing Tong, et al.. (2022). Rational Design and Synthesis of 3-Morpholine Linked Aromatic-Imino-1H-Indoles as Novel Kv1.5 Channel Inhibitors Sharing Vasodilation Effects. Frontiers in Molecular Biosciences. 8. 805594–805594. 1 indexed citations
11.
Sun, Xiaoying, Xin‐Fu Zhou, Aihong Li, et al.. (2022). Research Advances on Matrine. Frontiers in Chemistry. 10. 867318–867318. 60 indexed citations
12.
Tsai, Tzu‐Hsien, An‐Sheng Lee, Kuan‐Cheng Chang, et al.. (2022). Tumor endothelial marker 1 is upregulated in heart after cardiac injury and participates in cardiac remodeling. Scientific Reports. 12(1). 10532–10532. 6 indexed citations
13.
Ho, Ming-Yun, Po‐Wei Chen, Chun-Hung Su, et al.. (2021). Effect of aspirin treatment duration on clinical outcomes in acute coronary syndrome patients with early aspirin discontinuation and received P2Y12 inhibitor monotherapy. PLoS ONE. 16(5). e0251109–e0251109. 1 indexed citations
14.
Liu, Yen-Wen, Cheng‐Han Lee, Chi‐Ying Lee, et al.. (2021). Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents. iScience. 24(9). 103082–103082. 6 indexed citations
15.
Chen, Ju‐Yi, et al.. (2020). Urine High-Sensitivity Troponin I Predict Incident Cardiovascular Events in Patients with Diabetes Mellitus. Journal of Clinical Medicine. 9(12). 3917–3917. 39 indexed citations
16.
Li, Yi‐Heng, et al.. (2015). NATIONAL AUDIT PROJECT TO IMPROVE THE QUALITY OF CARE FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN TAIWAN. Journal of the American College of Cardiology. 65(10). A136–A136. 1 indexed citations
17.
18.
Li, Yi‐Heng, et al.. (2009). In-Hospital Initiation of Statins Therapy Improves the Clinical Outcomes in Patients With Acute Ischemic Stroke. Journal of the American College of Cardiology. 53(10). 1 indexed citations
19.
Li, Yi‐Heng, et al.. (1997). Elevation of Soluble Adhesion Molecules Is Associated With the Severity of Myocardial Damage in Acute Myocardial Infarction. The American Journal of Cardiology. 80(9). 1218–1221. 45 indexed citations
20.
Li, Yi‐Heng, et al.. (1993). Acute Myocardial Infarction and Left Ventricular Aneurysm in a Patient with Normal Coronary Arteries. Cardiology. 83(4). 280–284. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Songbai Deng Breakdown of academic impact, for papers by C. Abletshauser Breakdown of academic impact, for papers by Pyung Chun Oh Breakdown of academic impact, for papers by Simon Kouz Breakdown of academic impact, for papers by Binh An P. Phan Breakdown of academic impact, for papers by Tadeusz Osadnik Breakdown of academic impact, for papers by Fabio Marsico Breakdown of academic impact, for papers by Michael J. Blaha Breakdown of academic impact, for papers by Marija Vavlukis Breakdown of academic impact, for papers by Pierre Sabouret
Rankless by CCL
2026